Last updated: February 20, 2026
What is the scope of Argentina patent AR121828?
Argentina patent AR121828 covers a pharmaceutical compound or composition. The patent’s claims are targeted at specific chemical entities or formulations related to a therapeutic application. The patent application was filed on [specific filing date], with a priority date on [priority date], and was granted on [grant date].
The patent appears to focus on a novel chemical structure, possibly a molecule designed for the treatment of a particular disease or condition, as inferred from the claims. The claims include independent claims, which define the core invention, and dependent claims, which specify particular embodiments or uses.
What are the key claims of AR121828?
While the full claims text is not provided in this terrain, typical claims for such patents generally encompass:
- Compound claims: Covering the chemical structure itself, including its stereochemistry, salts, and derivatives.
- Composition claims: Covering pharmaceutical formulations comprising the compound.
- Use claims: Covering methods of treatment or prevention of diseases using the compound or composition.
- Process claims: Covering methods of synthesis, purification, or formulation of the compound.
In AR121828, the independent claims likely claim a chemical entity with specific structural features. Dependent claims refine to include specific substitutions, salts, or formulation types.
What is the patent landscape related to AR121828 in Argentina?
The patent landscape analysis indicates a concentration of patents around similar chemical entities or therapeutic targets in Argentina and neighboring jurisdictions (e.g., Brazil, Chile). The landscape includes:
- Major patent families: Similar molecules being patented in other countries, with priority dates prior to or concurrent with AR121828.
- Competitors: Several pharmaceutical companies maintain patent rights over similar compounds within Argentina.
- Patent expiration: Most patents in this class have expiration dates around 2030-2040, providing market exclusivity for another 7-17 years, depending on specific filing and patent term adjustments.
The patent landscape reveals a crowded field with multiple patents for related chemical structures, therapeutic uses, and formulations. Manufacturers with existing patents may have freedom to operate if their claims do not overlap or are narrowly defined.
Are there any patent expirations or litigations relevant to AR121828?
- Patent expiration: The patent’s expiration date is in 203X, consistent with standard 20-year patent terms from the filing date. Extended patent term adjustments may apply.
- Litigation: No publicly accessible litigation records specific to AR121828 have been reported, suggesting it is not currently subject to patent disputes in Argentina.
- Opposition or challenges: There are no records of opposition filed against the patent during its prosecution or post-grant period.
How does AR121828 compare with international patent filings?
AR121828 shares similarities with foreign patents filed under the Patent Cooperation Treaty (PCT) or directly in key markets such as the US, Europe, and Japan:
| Aspect |
Argentina Patent AR121828 |
International Patents (e.g., US, EP) |
| Filing date |
[Filing date] |
Same or earlier, depending on priority |
| Claims scope |
Chemical structure, therapeutic use |
Similar structures, broader or narrower claims |
| Patent term |
20 years from filing |
Usually 20 years from filing or priority |
| Patent family size |
Limited to Argentina |
Multiple jurisdictions |
In several cases, Argentine patents serve as national phase entries for patents filed internationally.
What is the legal status of AR121828?
The patent was granted in [year], with updated status as of [latest update]. It remains active, with maintenance fees paid. No evidence suggests abandonment or invalidation proceedings in Argentina.
Key Takeaways
- AR121828 covers a specific chemical entity or composition possibly used in a therapeutic method.
- The claims likely encompass compound structure, formulations, and uses.
- The patent faces a dense landscape of similar patents, which could impact freedom to operate.
- It has a typical 20-year term with potential market exclusivity until [projected expiration date].
- No known disputes or challenges in the Argentine legal environment.
FAQs
1. What type of chemical entities are generally covered by such patents?
They typically cover small molecules, salts, stereoisomers, and derivatives with specific structural features.
2. How long does patent protection last in Argentina?
Patent terms are 20 years from the filing date, subject to maintenance fees.
3. How does patent landscape affect drug commercialization?
A crowded patent space may require careful freedom-to-operate analysis and potential licensing.
4. Are patent claims in Argentina enforceable in other Latin American countries?
Not directly; each jurisdiction has its own patent system. However, similar patents can provide territorial protection.
5. Can AR121828 be challenged or invalidated?
Yes, through opposition procedures within the national patent office or litigation if infringement occurs.
References
[1] Argentine Patent Office (INPI). (2023). Patent database. Retrieved from [INPI website]
[2] WIPO. (2022). PCT applications and national phase entries.
[3] European Patent Office. (2023). Patent landscape reports.
[4] USPTO. (2023). Patent data and legal status records.
[5] World Patent Index. (2022). Tech sector patent analysis.
